This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Melanomas of skin
  • /
  • Nivolumab versus chemotherapy in patients with adv...
Journal

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Read time: 2 mins
Published:1st Apr 2015
Author: Weber JS, D'Angelo SP, Minor D, Hodi FS, Gutzmer R, Neyns B, et al.
Availability: Pay for access, or by subscription
Ref.:Lancet Oncol. 2015 Apr;16(4):375-84.
DOI:10.1016/S1470-2045(15)70076-8.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest